Compared to the common recommendation of screening for cystic fibrosis carrier status in Caucasians [59–61], our study revealed that only 0.97% of our sample carried pathogenic variants (PV) and likely pathogenic variants (LPV) in the CFTR gene. This evidence concerns the gene CFTR and cystic fibrosis.